The current valuation score of Lexeo Therapeutics Inc is 6.62, ranking 308 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.97, which is -86.35% below the recent high of -0.54 and -74.37% above the recent low of -6.92.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.